Showing results (321-330 of 728) with videos related to
Sort By:
Pageof 73
Melanoma Research|May 24, 2012
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanomaLise Hoejberg, Lars Bastholt, Julia S Johansen, et al.Acta Medica Scandinavica|January 1, 1987
Bone metabolism and bone status in osteoporotic patientsD Hartwell, B J Riis, C Christiansen, et al.BJU International|May 5, 2019
The epidemiology of bacille Calmette-Guérin infections after bladder instillation from 2002 through 2017: a nationwide retrospective cohort studyEmilie S Larsen, Anne C Nordholm, Troels Lillebaek, et al.Ugeskrift for Laeger|April 11, 2001
[Resistant tuberculosis in Denmark]V O Thomsen, I S Johansen, J O Bauer, et al.Cytokine|April 12, 2011
IL-6, but not TNF-α, increases plasma YKL-40 in human subjectsAnders R Nielsen, Peter Plomgaard, Karen S Krabbe, et al.Immunobiology|January 3, 2012
The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failureMarina Harutyunyan, Michael Christiansen, Julia S Johansen, et al.Journal of Colloid and Interface Science|March 9, 2005
Enzymatic degradation of model cellulose filmsJonny Eriksson, Martin Malmsten, Fredrik Tiberg, et al.Cell and Tissue Research|April 1, 1995
Tissue kinetics, ion transport, and recruitment of mitochondria-rich cells in the skin of the toad (Bufo bufo) in response to exposure to distilled waterP E Budtz, B C Christoffersen, J S Johansen, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1991
Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-linksD Uebelhart, A Schlemmer, J S Johansen, et al.Oncotarget|February 23, 2018
Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trialMogens K Boisen, Camilla B Holst, Nicola Consalvo, et al.Pageof 73